Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baikangling Zhenyuan Tablets (also known as Zhenyuan Pian) is a traditional Chinese medicine (TCM) developed and manufactured by Anhui Jiuhua Huayuan Pharmaceutical. The active ingredient is total saponins extracted from the fruit of *Panax ginseng*. Each 0.24g film-coated tablet contains 25mg of these total ginseng fruit saponins. The medication is indicated for its nourishing and strengthening effects, specifically to treat dizziness, fatigue, neurasthenia, and endocrine disorders. It is also used to provide anti-fatigue, anti-stress, and anti-hypoxia benefits and to address symptoms of premature aging. As a traditional herbal formulation, its specific molecular targets and biological mechanisms of action are not fully defined in conventional pharmacological terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baikangling Zhenyuan Tablets.